 CAMBRIDGE, Mass.--BUSINESS WIRE--- ALVR celltherapy--AlloVir, Inc. Nasdaq: ALVR, a late clinical-stage cell therapy company, will present a corporate overview at the 10th Annual SVB Leerink Global Healthcare Conference on February 26, 2021 at 4:20 p.m. ET. The presentation will be available on the Investors Press section of the AlloVir website at An archived replay of the presentation will be available for approximately 30 days following the presentation. About AlloVir AlloVir is 